MedTrace Logo

Angiographic and IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

NCT01382043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2018-03-21

No results posted yet for this study

Summary

The safety and efficacy of drug-eluting stents (DES) with a biocompatible polymer have been demonstrated in randomized clinical trials as well as in real world practice. Theoretically, a new DES with a biodegradable polymer should reduce the incidence of late in-stent thrombosis, however, the long-term safety and efficacy of these stents remains unknown. This study was aimed to compare the safety and efficacy of the Excel DES with a biodegradable polymer to the Endeavor DES with a biocompatible polymer in same individuals.

Conditions

  • Percutaneous Coronary Angioplasty

Sponsors & Collaborators

  • Liuhuaqiao Hospital

    lead OTHER

Principal Investigators

  • Dingcheng Xiang, Dr. · Liuhuaqiao Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-09-30
Completion
2011-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01382043 on ClinicalTrials.gov